{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:17:27Z","timestamp":1760188647371},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.1007\/bf02088068","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T08:36:48Z","timestamp":1124008608000},"page":"1581-1585","source":"Crossref","is-referenced-by-count":16,"title":["Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat"],"prefix":"10.1007","volume":"39","author":[{"given":"P. E.","family":"Queneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bertault-Peres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Guitaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mesdjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Montet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02088068_CR1","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/bi00515a052","volume":"20","author":"MC Carey","year":"1981","unstructured":"Carey MC, Montet JC, Phillips MC, Armstrong MJ, Mazer NA: Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates. Biochemistry 20:3637\u20133648, 1981","journal-title":"Biochemistry"},{"key":"BF02088068_CR2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"324","author":"RE Poupon","year":"1991","unstructured":"Poupon RE, Balkau B, Eschw\u00e8ge E, Poupon R, and the UDCA-PBC study group: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324:1548\u20131554, 1991","journal-title":"N Engl J Med"},{"key":"BF02088068_CR3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","volume":"14","author":"CB O'Brien","year":"1991","unstructured":"O'Brien CB, Senior JR, Arora-Mirchandani R, Batta AK, Salen G: Ursodeoxycholic acid for the treatment of primary sclerosis cholangitis: A 30-month pilot study. Hepatology 14:838\u2013847, 1991","journal-title":"Hepatology"},{"key":"BF02088068_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(05)82561-2","volume":"121","author":"C Galabert","year":"1992","unstructured":"Galabert C, Montet JC, Lengrand D, Lecuire A, Sotta C, Figarella C, Chazalette JP: Effects of ursodeoxycholic acid on liver function tests in patients with cystic fibrosis and chronic cholestasis. J Pediatr 121:138\u2013141, 1992","journal-title":"J Pediatr"},{"key":"BF02088068_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.1840150612","volume":"15","author":"J Palma","year":"1992","unstructured":"Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, Alvarez C, Molina J, Danitz AM: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 15:1043\u20131047, 1992","journal-title":"Hepatology"},{"key":"BF02088068_CR6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0016-5085(90)90032-V","volume":"98","author":"M Podda","year":"1990","unstructured":"Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A: Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 98:1044\u20131050, 1990","journal-title":"Gastroenterology"},{"key":"BF02088068_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","volume":"11","author":"Y Calmus","year":"1990","unstructured":"Calmus Y, Gane P, Rouger P, Poupon R: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid. Hepatology 11:12\u201315, 1990","journal-title":"Hepatology"},{"key":"BF02088068_CR8","first-page":"389","volume":"24","author":"S Friman","year":"1992","unstructured":"Friman S, Persson H, Scherst\u00e9n T, Svanvik J, Karlberg I: Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation. Transplant Proc 24:389\u2013390, 1992","journal-title":"Transplant Proc"},{"key":"BF02088068_CR9","first-page":"377","volume":"15","author":"O Wagner","year":"1987","unstructured":"Wagner O, Schreier E, Heitz F, Maurer G: Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab Dispos 15:377\u2013383, 1987","journal-title":"Drug Metab Dispos"},{"key":"BF02088068_CR10","first-page":"46","volume":"18","author":"GJ Burckart","year":"1986","unstructured":"Burckart GJ, Starzl TE, Venkataramanan R, Hashim H, Wong L, Wang P, Makowka L, Zeevi A, Ptachcinski RJ, Knapp KE, Iwatsuki S, Esquivel C, Sanghvi A, Van Thiel DH: Excretion of cyclosporine and its metabolites in human bile. Transplant Proc 18:46\u201349, 1986","journal-title":"Transplant Proc"},{"key":"BF02088068_CR11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-2275(20)40709-6","volume":"19","author":"SB Turley","year":"1978","unstructured":"Turley SB, Dietschy JM: Re-evaluation of the 3\u03b1-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 19:924\u2013928, 1978","journal-title":"J Lipid Res"},{"key":"BF02088068_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-2275(20)39833-3","volume":"21","author":"H Fromm","year":"1980","unstructured":"Fromm H, Amin P, Klein H, Kupke I: Use of a simple enzymatic assay for cholesterol analysis in human bile. J Lipid Res 21:259\u2013261, 1980","journal-title":"J Lipid Res"},{"key":"BF02088068_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0009-8981(72)90256-2","volume":"40","author":"J Amic","year":"1972","unstructured":"Amic J, Lairon D, Hauton J: Technique de dosage automatique de l'orthophosphate de grande fiabilit\u00e9. Clin Chim Acta 40:107\u2013114, 1972","journal-title":"Clin Chim Acta"},{"key":"BF02088068_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0016-5085(87)91025-0","volume":"93","author":"BG Stone","year":"1987","unstructured":"Stone BG, Udani M, Sanghvi A, Warty V, Plocki K, Bedetti CD, Van Thiel DH: Cyclosporin A-induced cholestasis. The mechanism in a rat model. Gastroenterology 93:344\u2013351, 1987","journal-title":"Gastroenterology"},{"key":"BF02088068_CR15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00007890-198810000-00008","volume":"46","author":"B Thai Le","year":"1988","unstructured":"Le Thai B, Dumont M, Michel A, Erlinger S, Houssin D: Cholestatic effect of cyclosporine in the rat. An inhibition of bile acid secretion. Transplantation 46:510\u2013512, 1988","journal-title":"Transplantation"},{"key":"BF02088068_CR16","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/0006-2952(81)90604-3","volume":"30","author":"MJG Farthing","year":"1981","unstructured":"Farthing MJG, Clark ML, Pendry A, Sloane J, Alexander P: Nature of the toxicity of cyclosporin A in the rat. Biochem Pharmacol 30:3311\u20133316, 1981","journal-title":"Biochem Pharmacol"},{"key":"BF02088068_CR17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0955-2863(90)90116-3","volume":"1","author":"XM Zhao","year":"1990","unstructured":"Zhao XM, Montet JC: Effects of bile salt supplementation on biliary secretion in estrogen-treated rats. J Nutr Biochem 1:420\u2013425, 1990","journal-title":"J Nutr Biochem"},{"key":"BF02088068_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3181\/00379727-199-43327","volume":"199","author":"R Utili","year":"1992","unstructured":"Utili R, Tripodi MF, Abernathy CO, Zimmerman HJ, Gillespie J: Effects of bile salt infusion on chlorpromazine-induced cholestasis in the isolated perfused rat liver. Proc Soc Exp Biol Med 199:49\u201353, 1992","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02088068_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0016-5085(91)90602-H","volume":"100","author":"DM Heuman","year":"1991","unstructured":"Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR: Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts.In vivo studies in the rat. Gastroenterology 100:203\u2013211, 1991","journal-title":"Gastroenterology"},{"key":"BF02088068_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-2275(20)38175-X","volume":"23","author":"MJ Armstrong","year":"1982","unstructured":"Armstrong MJ, Carey MC: The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. J Lipid Res 23:70\u201380, 1982","journal-title":"J Lipid Res"},{"key":"BF02088068_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0024-3205(82)90264-8","volume":"30","author":"K Kitani","year":"1982","unstructured":"Kitani K and Kanai S: Tauroursodeoxycholate prevents taurocholate induced cholestasis. Life Sci 30:515\u2013523, 1982","journal-title":"Life Sci"},{"key":"BF02088068_CR22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840120307","volume":"12","author":"PR Galle","year":"1990","unstructured":"Galle PR, Thielmann L, Raedsch R, Otto G, Stiehl A: Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 12:486\u2013491, 1990","journal-title":"Hepatology"},{"key":"BF02088068_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0955-2863(93)90008-K","volume":"4","author":"XM Zhao","year":"1993","unstructured":"Zhao XM, Montet AM, Montet JC: \u03b2-Muricholic acid: A new hepatoprotective agent. J Nutr Biochem 4:105\u2013112, 1993","journal-title":"J Nutr Biochem"},{"key":"BF02088068_CR24","first-page":"470","volume":"17","author":"T Ohiwa","year":"1993","unstructured":"Ohiwa T, Katagiri K, Hoshino M, Hayakawa T, Nakai T: Tauroursodeoxycholate and tauro \u03b2-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. Hepatology 17:470\u2013476, 1993","journal-title":"Hepatology"},{"key":"BF02088068_CR25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(87)92421-4","volume":"2","author":"AF Hofmann","year":"1987","unstructured":"Hofmann AF, Popper H: Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 2:398\u2013399, 1987","journal-title":"Lancet"},{"key":"BF02088068_CR26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0016-5085(88)80028-3","volume":"95","author":"NH Stacey","year":"1988","unstructured":"Stacey NH, Kotecka B: Inhibition of taurocholate and ouabain transport in isolated rat hepatocytes by cyclosporin A. Gastroenterology 95:780\u2013786, 1988","journal-title":"Gastroenterology"},{"key":"BF02088068_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0005-2736(88)90120-4","volume":"938","author":"K Ziegler","year":"1988","unstructured":"Ziegler K, Polzin G, Frimmer M: Hepatocellular uptake of cyclosporin A by simple diffusion. Biochim Biophys Acta 938:44\u201350, 1988","journal-title":"Biochim Biophys Acta"},{"key":"BF02088068_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0005-2736(86)90197-5","volume":"855","author":"K Ziegler","year":"1986","unstructured":"Ziegler K, Frimmer M: Cyclosporin A and a diaziridine derivative inhibit the hepatocellular uptake of cholate, phalloidin and rifampicin. Biochim Biophsy Acta 855:136\u2013142, 1986","journal-title":"Biochim Biophsy Acta"},{"key":"BF02088068_CR29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","volume":"321","author":"BD Kahan","year":"1989","unstructured":"Kahan BD: Cyclosporine. N Engl J Med 321:1725\u20131738, 1989","journal-title":"N Engl J Med"},{"key":"BF02088068_CR30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-2275(20)37948-7","volume":"24","author":"G Salvioli","year":"1983","unstructured":"Salvioli G, Igimi H, Carey MC: Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: Dissimilar phase equilibria and dissolution mechanisms. J Lipid Res 24:701\u2013720, 1983","journal-title":"J Lipid Res"},{"key":"BF02088068_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(87)90002-6","volume":"918","author":"JC Montet","year":"1987","unstructured":"Montet JC, Parquet M, Sacquet E, Montet AM, Infante R, Amic J: \u03b2-Muricholic acid; potentiometric and cholesterol-dissolving properties. Biochim Biophys Acta 918:1\u201310, 1987","journal-title":"Biochim Biophys Acta"},{"key":"BF02088068_CR32","first-page":"134","volume":"17","author":"PH Whiting","year":"1985","unstructured":"Whiting PH, Thomson AW, Simpson JG: Cyclosporine: Toxicity, metabolism, and drug interactions. Implications from animal studies. Transplant Proc 17:134\u2013144, 1985","journal-title":"Transplant Proc"},{"key":"BF02088068_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000183583","volume":"41","author":"MJD Cassidy","year":"1985","unstructured":"Cassidy MJD, Van Zyl-Smit R, Pascoe MD, Swanepoel CR, Jacobson JE: Effect of rifampicin on cyclosporine A blood levels in a renal transplant recipient. Nephron 41:207\u2013208, 1985","journal-title":"Nephron"},{"key":"BF02088068_CR34","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(85)91746-5","volume":"1","author":"RDM Allen","year":"1985","unstructured":"Allen RDM, Hunniset AG, Morris PJ: Cyclosporine and rifampicin in renal transplantation. Lancet 1:980, 1985","journal-title":"Lancet"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02088068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02088068\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02088068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T18:42:26Z","timestamp":1626374546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02088068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["BF02088068"],"URL":"https:\/\/doi.org\/10.1007\/bf02088068","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}